Journal of Cardiac Critical Care TSS最新文献

筛选
英文 中文
Extracorporeal Life Support Organization Registry Report 2022 体外生命支持组织注册报告2022
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1757394
P. Rycus, Christine M. Stead
{"title":"Extracorporeal Life Support Organization Registry Report 2022","authors":"P. Rycus, Christine M. Stead","doi":"10.1055/s-0042-1757394","DOIUrl":"https://doi.org/10.1055/s-0042-1757394","url":null,"abstract":"","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73638694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
COVID 19: Airway Management and Pharmacological Strategies COVID - 19:气道管理和药理策略
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1759862
S. Chandra, Aditi Narang, P. Choudhuri, Kapil Gupta
{"title":"COVID 19: Airway Management and Pharmacological Strategies","authors":"S. Chandra, Aditi Narang, P. Choudhuri, Kapil Gupta","doi":"10.1055/s-0042-1759862","DOIUrl":"https://doi.org/10.1055/s-0042-1759862","url":null,"abstract":"Abstract Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has since resulted in more than 250 million cases worldwide and over 50 million deaths. Although treatment is mainly supportive, with oxygen therapy being the mainstay, various pharmacological treatment modalities have also been explored. In this review, we have evaluated the available evidence on airway management as well as medical management and highlighted the possible interventions that may be effective in care of critically ill patients.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"10 1","pages":"210 - 215"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82891424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transesophageal Echocardiographic Illustration of Postinfarction Ventricular Septal Rupture 经食道超声心动图显示梗死后室间隔破裂
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1757368
Devishree Das, M. Prakash, N. Makhija
{"title":"Transesophageal Echocardiographic Illustration of Postinfarction Ventricular Septal Rupture","authors":"Devishree Das, M. Prakash, N. Makhija","doi":"10.1055/s-0042-1757368","DOIUrl":"https://doi.org/10.1055/s-0042-1757368","url":null,"abstract":"Postinfarction ventricular septal rupture (VSR) is a rare but dreaded mechanical complication of myocardial infarction. Moreover, patient develops cardiogenic shock or congestive heart failure requiring early surgical intervention. To optimize surgical repair, perioperative confirmation, determining location of VSR and adequacy of repair, is mandatory. Assessment can be obtained by the transesophageal echocardiography (TEE). Use of two- and three-dimensional TEE techniques clearly delineate size and shape of septal rupture and involvement of other cardiac structures. We report a patient presenting with postinfarction VSR for elective VSR repair and surgical revascularization and implication of TEE in perioperative management.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"108 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86257370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should We Implement Type and Screen Transfusion Policy in Pediatric Cardiac Surgery to Improve Patient Blood Management? 小儿心脏外科是否应该实施输血类型和筛选政策以改善患者血液管理?
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1759830
S. Datta
{"title":"Should We Implement Type and Screen Transfusion Policy in Pediatric Cardiac Surgery to Improve Patient Blood Management?","authors":"S. Datta","doi":"10.1055/s-0042-1759830","DOIUrl":"https://doi.org/10.1055/s-0042-1759830","url":null,"abstract":"Bleeding during or after cardiac surgery is common in adults and associated with signi fi cant utilization of blood products. 1 There is very little evidence available on patient blood management in pediatric cardiac surgery. Children typically receive transfusions perioperatively for many reasons, including developmental alterations of their hemostatic sys-tem, hemodilution, and hypothermia with cardiopulmonary bypass, systemic anticoagulation, etc. The complexity of their surgical procedures, complex cardiopulmonary inter-actions, and risk for inadequate oxygen delivery and post-operative bleeding further contribute to blood product utilization in this vulnerable population. Till date, most of the blood centers in India follow blood typing and crossmatch policy as a part of pretransfusion testing to select the right blood for these patients. In this policy, patients are typed for their ABO/RhD and received red cell transfusions based on the antihuman globulin crossmatch results. However, in type and screen policy, the transfusion services perform ABO/RhD typing and a screen for atypical antibodies of the patient ’ s blood and plasma. A negative antibodyscreen signi fi es that the patient does not demonstrate any clinically signi fi cant antibodies and, therefore, only an immediate spin or abbreviated crossmatch is required. Because an immediate spin crossmatch is a fairly simple test, taking approxi-mately 10minutes in comparison to full crossmatch that takes around 45minutes, blood is available rather quickly if the need should arise. Since blood is not unnecessarily crossmatched and reserved for a patient who might not","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"5 1","pages":"228 - 229"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78815484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Randomized Controlled Trial to Evaluate the Use of Probiotics in Prevention of Ventilator-Associated Pneumonia in Critically Ill ICU Patients 一项评估益生菌预防重症ICU患者呼吸机相关性肺炎的随机对照试验
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1754161
Anand Prasoon, R. Singh, R. Anand, Sanjeev Kumar, Siddharth Singh, A. Singh
{"title":"A Randomized Controlled Trial to Evaluate the Use of Probiotics in Prevention of Ventilator-Associated Pneumonia in Critically Ill ICU Patients","authors":"Anand Prasoon, R. Singh, R. Anand, Sanjeev Kumar, Siddharth Singh, A. Singh","doi":"10.1055/s-0042-1754161","DOIUrl":"https://doi.org/10.1055/s-0042-1754161","url":null,"abstract":"\u0000 Context Ventilator-associated pneumonia (VAP) is one of the most common causes of morbidity and mortality in mechanically ventilated patients. Curing and preventing effects of probiotics in promoting the growth of Bifidobacterium in the digestive system and the central role of bacteria colonization in the pathogenesis of VAP are evident.\u0000 Aims The purpose of this study was to evaluate the effects of administration of commercially available probiotics, that is, orodispersible probiotic sachets on VAP prevention and clinical outcomes in critically ill patients.\u0000 Settings and Design Randomized control trials.\u0000 Methods and Materials In this study, 120 mechanically ventilated patients were randomly divided into two groups (n = 60 per group). Group 1 was given orodispersible probiotic sachets by gavage, twice a day in addition to routine care, while group 2 received only routine care. Demographic and clinical data were analyzed and clinical outcomes to the primary component (prevalence of VAP) and secondary component (other clinical factors) were interpreted.\u0000 Statistical Analysis Used In this study, data were analyzed via SAS statistical software version 9.4, using Student's t-test, chi-squared test, repeated measure analysis of variance, and Wilcoxon test.\u0000 Results There was a significant reduction in VAP diagnosed patients, as well as Clostridium\u0000 difficile-associated diarrhea and some complications of mechanical ventilation, in group 1 in comparison to group 2. The improvement in VAP was significantly greater for group 1 as compared with group 2. However, the mortality rate was similar between two groups.\u0000 Conclusions This study demonstrated that a daily diet with orodispersible probiotic sachets can be used as add-on therapy with other medications in the prevention of VAP. As a result, the use of orodispersible probiotic sachets in the treatment plan of patients undergoing long-term intubation is recommended.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91311708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
ECMO and Ventricular Assist Devices as a Bridge to Transplant ECMO和心室辅助装置作为移植的桥梁
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1759861
P. Kapoor
{"title":"ECMO and Ventricular Assist Devices as a Bridge to Transplant","authors":"P. Kapoor","doi":"10.1055/s-0042-1759861","DOIUrl":"https://doi.org/10.1055/s-0042-1759861","url":null,"abstract":"Many cardiac diseases, like coronary artery disease and some viral cardiomyopathy over a period of time, give rise to the condition calledheart failure (HF).More than2million Indians suffer from HF today. The first line of management includes lifestyle modifications, as well as medical therapy. The latter uses drugs such as beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptors/blockers aldosterone antagonists, diuretics, digoxin, and many others keep getting added with more research and research and development today. Salt and fluid restriction too plays a pivotal role. Patients with a wide QRS complex in their electrocardiogram and thosehavingamoderate to severe symptomsofHFneed to have a cardiac resynchronization therapy and a patient with fatal arrhythmias needs an implantable defibrillator inserted as therapy. So, use of advanced mechanical therapies is a necessity in HF patient. Most HF Indians have class III or class IV symptoms of dyspnea at rest of some duration or a recent origin. In this scenario of advanced mechanical support in HF patient, the two definitive therapies of nearly 6,000 in number and still on the increase are the use of ventricular assist devices (VAD) and heart transplant,which havemet with some success (►Box 1). This editorial briefly revises extracorporeal membrane oxygenation (ECMO) as a bridge to transplant (►Figs. 1 and 2).","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"134 1","pages":"185 - 189"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89022442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative Fluid Therapy in Adult Cardiac Surgical Patients and Acute Kidney Injury: A Prospective Observational Study 成人心脏手术患者术后液体治疗和急性肾损伤:一项前瞻性观察研究
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1755434
M. Sahu, Seshagiribabu Yagani, S. Singh, U. Singh, Dharmraj Singh, Shivam Panday
{"title":"Postoperative Fluid Therapy in Adult Cardiac Surgical Patients and Acute Kidney Injury: A Prospective Observational Study","authors":"M. Sahu, Seshagiribabu Yagani, S. Singh, U. Singh, Dharmraj Singh, Shivam Panday","doi":"10.1055/s-0042-1755434","DOIUrl":"https://doi.org/10.1055/s-0042-1755434","url":null,"abstract":"\u0000 Background Normal saline (0.9% NS) is a common intravenous fluid used worldwide. Recent studies have shown that NS use is associated with increased incidence of acute kidney injury (AKI) and a need for renal replacement therapy (RRT). The practice is changing toward using balanced solutions to prevent AKI. Postcardiac surgery patients are more prone to develop AKI after cardiopulmonary bypass (CPB). We aim to study the type of fluid administrated, incidence of AKI, need for RRT, and overall outcome of these patients.\u0000 Methods This prospective observational study was conducted in the cardiothoracic intensive care unit (cardiothoracic and vascular surgery intensive care unit) in a cohort of 197 adult patients who underwent on pump cardiac surgery in our hospital from July 2021 to October 2021 as a pilot study. Data was analyzed using SPSS 20.0 (IBM, Chicago, Illinois, United States). A p-value < 0.05 was considered significant.\u0000 Results In our study, 58 (29.34%) patients developed AKI in the first three postoperative days and 16 (8.12%) patients required RRT. Incidence of AKI was found to be higher in patients who received NS only, as fluid of choice was 34.48% compared with other intravenous fluids. Patients with AKI had higher positive fluid balance (p < 0.001), longer CPB (p < 0.001), and aortic cross clamp (p = 0.006) times. Intensive care unit and hospital stay and mortality rates were higher in AKI patients than those without AKI (p < 0.001).\u0000 Conclusion Our study demonstrated that NS was the commonly used crystalloid in our patients and was associated with increased incidence of AKI and RRT when compared with other balanced salts solutions.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79366025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Vitamin D Supplementation on Postoperative Outcomes in Cardiac Surgery Patients: A Systematic Review 补充维生素D对心脏手术患者术后预后的影响:一项系统综述
Journal of Cardiac Critical Care TSS Pub Date : 2022-07-01 DOI: 10.1055/s-0042-1759822
Sambhunath Das, Punyatoya Bej
{"title":"Effect of Vitamin D Supplementation on Postoperative Outcomes in Cardiac Surgery Patients: A Systematic Review","authors":"Sambhunath Das, Punyatoya Bej","doi":"10.1055/s-0042-1759822","DOIUrl":"https://doi.org/10.1055/s-0042-1759822","url":null,"abstract":"Abstract Background  Vitamin D deficiency is a very common occurrence in cardiac patients. It has been proved that cardiac surgery and cardiopulmonary bypass accelerate the deficiency further. The postoperative outcomes of patients deteriorate in the presence of vitamin D deficiency. Perioperative supplementation of vitamin D is the only solution to the problem. Hence, the present systematic review was conducted to derive the efficacy and safety of vitamin D supplementation on postoperative outcomes in cardiac surgery patients. Method  Publications over duration of last 10 years was searched from different database and web sites. The data from full-text research articles were analyzed for the effect on different postoperative outcomes and side effects. Result  Eight randomized control trials were retrieved on the effect of perioperative vitamin D supplementation in cardiac surgery patients and their postoperative outcomes. Six articles (75%) were found to be in favor of improvement in postoperative outcome. Two articles (25%) did not find any difference of outcome between the control and treatment group. All the studies observed the restoration of vitamin D to normal and no adverse effects from supplementation. Conclusion  Perioperative vitamin D supplementation improves the postoperative outcomes after cardiac surgery. It is effective and safe to supplement vitamin D in cardiac surgery patients.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"1 1","pages":"195 - 200"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88592336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evolution of a Parsimonious Prognostic Index in COVID-19 COVID-19简约预后指标的演变
Journal of Cardiac Critical Care TSS Pub Date : 2022-06-29 DOI: 10.1055/s-0042-1750197
Armaanjeet Singh, R. Kashav, R. Magoon, Iti Shri, Jasvinder K Kohli
{"title":"Evolution of a Parsimonious Prognostic Index in COVID-19","authors":"Armaanjeet Singh, R. Kashav, R. Magoon, Iti Shri, Jasvinder K Kohli","doi":"10.1055/s-0042-1750197","DOIUrl":"https://doi.org/10.1055/s-0042-1750197","url":null,"abstract":"In the December 2021 issue of the Journal of Cardiac Critical Care, we proposed a promising prognostic index, shock index (SI) for risk-stratifying the patients ailing from coronavirus disease 2019 (COVID-19).1 While it is indeed gratifying to witness an increasing research interest in the subject,2–5 the elucidation of nuances of the accruing literature would be of potential interest to the readers of the Journal. Reiterating the basics of the classically described prognostic index, SI is computed as the ratio of heart rate (HR) to systolic blood pressure (SBP).6 Alongside being conducive to the prediction of hemodynamic instability in patients with myocardial infarction and sepsis, the former has also been propounded as a prognostic marker for the in-hospital mortality prediction.7 Notably, a normal SI (0.5–0.7) along with the absence of an elevated lactate level has been associated with a very low risk for severe sepsis at presentation.8 Talking specifically of SI-based prognostication in COVID-19, there have been four studies that analyzed the merit of SI among patients with COVID-19 over the past 2 years of the pandemic. The first study by Doğanay et al provided results in favor of the mortality predictive value of SI.2 In a retrospective evaluation of 489 COVID-19 patients using CHAID (Chi-Square Automatic Interaction Detection Technique\" is a statistical tool used for comparing relationship between variables) analysis, they highlighted SI as the factor with the highest predictive value within any given age group with a cutoff of 0.93. They also noted an increase in the association of SI and mortality with advanced age (mortality in patients with SI>0.93 and age<56 years old1⁄426.9%, 56–77 years1⁄480.5%,>77 years1⁄491.4%). These results were corroborated by Kurt et al in their efforts to investigate the mortality predictive potential of SI and modified SI (HR/mean arterial pressure).3 Using the data of 464 patients evaluated retrospectively, they noted a higher predictive power of modified SI compared with SI (DeLong’s test, AUC difference1⁄4–0.020, p1⁄40.003). Similarly, a research endeavor by Ak et al compared various threshold values of SI (0.7, 0.8, 0.9, and 1.0) in 364 COVID-19 cases to assess the predictive performance in terms of intensive care unit (ICU) admission and mortality rate.4 A pre-hospital SI>0.9 was found to be predictive of a higher ICU admission and mortality rate. While these studies show a beneficial aspect of employing SI in risk stratification of COVID-19 patients, van Rensen et al could not elicit a similar result in their study. Their retrospective analysis of 411 patients revealed no discernible discriminative potential of SI for ICU admission and mortality in COVID-19 patients.5 Being a purely hemodynamic parameter, SI emerges as a useful metric for physiological status monitoring.9 At the same time, the inclusion of other vital-system monitoring parameters in SI can buttress the subsequent prognostic potential.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84657348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mucormycosis: An Uncommon Cutaneous Infection at Permanent Pacemaker-Implanted Site in a Very Low-Birthweight Baby 毛霉病:非常低出生体重婴儿永久性起搏器植入部位的罕见皮肤感染
Journal of Cardiac Critical Care TSS Pub Date : 2022-01-14 DOI: 10.1055/s-0041-1739522
Minati Choudhury, J. Narula, M. Hote, S. Mohapatra
{"title":"Mucormycosis: An Uncommon Cutaneous Infection at Permanent Pacemaker-Implanted Site in a Very Low-Birthweight Baby","authors":"Minati Choudhury, J. Narula, M. Hote, S. Mohapatra","doi":"10.1055/s-0041-1739522","DOIUrl":"https://doi.org/10.1055/s-0041-1739522","url":null,"abstract":"Permanent pacemaker implantation in low birthweight (LBW) babies with congenital complete heart block is extremely challenging due to a paucity of appropriate pulse generator placement pocket sites. The development of infection following an implantation procedure can pose a life-threatening risk to the patients. With more patients in the younger group receiving these devices than ever before and the rate of infection increasing rapidly, a closer look at the burden of infection and its impact on outcome of these patients is warranted. We report mucormycosis infection at the abdominal pacemaker pocket site of an infant requiring pacemaker explantation and re-insertion into the intrapleural space.","PeriodicalId":34567,"journal":{"name":"Journal of Cardiac Critical Care TSS","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91236979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信